Want to join the conversation?
$XRAY 2Q15 PR: Bret Wise, DENTSPLY's Chairman and CEO, stated "Given our first half results, recent strength in the US market, and in light of a relatively stable European dental market, we are increasing our full-year adjusted earnings guidance to the range of $2.54 to $2.62 per diluted share from $2.50 to $2.60 per share, previously."
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?